Can a smartphone app get people with 'Four Highs' moving more?

NCT ID NCT07400549

Recruiting now Disease control Sponsor: China National Center for Cardiovascular Diseases Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a mini-program (like a smartphone app) that gives personalized exercise advice to people with high blood pressure, high blood sugar, high cholesterol, and high uric acid. Over six months, 100 participants will use the app to increase their daily steps and physical activity. The goal is to see if this digital tool can help manage these conditions better in primary care settings.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: exercise prescription mini-program
What this could lead to: If successful, this could provide a simple, scalable digital tool to help people manage multiple chronic conditions through better exercise habits.
What could go wrong: This is a small, early exploratory study with only 100 participants, so results may not apply broadly. The intervention is behavioral, so adherence and long-term effects are uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIGITAL INTERVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hyperglycemia hyperlipidemia hypertensive disorder Hyperuricemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIGITAL INTERVENTION HYPERGLYCEMIA HYPERLIPIDEMIA HYPERTENSION HYPERURICEMIA

Contacts and locations

Show contact details

Study contacts

Contact

Email: •••••@•••••

Locations

Fuwai Hospital, Chinese Academy of MedicL Sciences
RECRUITING

Beijing, 100061, China

Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.